France’s top health authority has already cleared Covid-19 vaccine AstraZeneca for public use but advised that it should only be given to people under 65 years old. Such restrictions were recommended due to insufficient data on its efficacy for older people. The European Union already approved the vaccine for all adults but the member countries are free to set their own rollout policy. The slow pace of vaccinations met criticisms and there were also delays in delivering vaccines from AstraZeneca and Pfizer among many others. However, European Commission president, Ursula von der Leyen, maintained her firm stance that the EU had made the right decision.

Over 1.5 million people in France have received the Covid-19 vaccine as of writing. It was made by AstraZeneca, a UK-Swedish pharmaceutical firm. Research has shown that the vaccine is safe and has an average of 70% efficacy. So far, the people who received this vaccine have never experienced any serious illnesses nor been hospitalized due to the novel coronavirus.